Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/559
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGupta, Satish Kumar-
dc.date.accessioned2015-05-29T10:33:32Z-
dc.date.available2015-05-29T10:33:32Z-
dc.date.issued2014-03-
dc.identifier.urihttp://hdl.handle.net/123456789/559-
dc.description.abstractPROBLEM: The aim of this study was to investigate the relative importance of STAT3 and ERK1/2 activation in leukaemia inhibitory factor (LIF)-mediated invasion of JEG-3 cells. METHOD OF STUDY: Matrigel matrix-based invasion assay; Western blot; cDNA microarray; quantitative RT-PCR; gene silencing by siRNA. RESULTS: Leukaemia inhibitory factor treatment led to the activation of STAT3 and ERK1/2 signaling pathways which was followed by changes in the expression of several invasion-associated molecules such as mucin1 (MUC1), Fos, Jun, etc. Abrogation of either STAT3 or ERK1/2 signaling reduced (P < 0.05) the LIF-mediated invasion of JEG-3 cells. It was associated with a significant reduction in the expression of both MUC1 and Fos, suggesting a common denominator in LIF-STAT3-ERK1/2 signaling. To this effect, we observed a decrease in LIF-mediated p-STAT3 (Ser727) upon blocking STAT3 or ERK1/2 signaling. CONCLUSIONS: ERK1/2 as well as JAK-STAT-mediated STAT3 (Ser727) phosphorylation play an important role in LIF-mediated JEG-3 trophoblastic cell invasion and gene expression.en_US
dc.publisherWileyen_US
dc.titleSTAT3 and ERK1/2 Cross-talk in Leukaemia Inhibitory Factor Mediated Trophoblastic JEG-3 Cell Invasion and Expression of Mucin 1 and Fosen_US
dc.contributor.coauthorPankaj Suman-
dc.keywordERK1/2, JEG-3, Leukaemia inhibitory factor, microarray, STAT3, trophoblast invasionen_US
dc.journalAm J Reprod Immunol.en_US
dc.volumeno72en_US
dc.issueno1en_US
dc.pages65-74en_US
Appears in Collections:Reproductive Cell Biology, Publications

Files in This Item:
File Description SizeFormat 
10.pdf435.55 kBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.